David D. Allison - 11 Jul 2021 Form 4 Insider Report for IMPEL NEUROPHARMA INC

Role
Director
Signature
/s/ John Leaman, M.D. as attorney-in-fact
Issuer symbol
N/A
Transactions as of
11 Jul 2021
Net transactions value
$0
Form type
4
Filing time
13 Jul 2021, 17:05:27 UTC
Next filing
06 Jan 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IMPL Stock Option (right to buy) Award $0 +11,500 $0.000000 11,500 11 Jul 2021 Common Stock 11,500 $9.96 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option is 100% vested on July 11, 2022.